Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer

被引：0
|
作者：
Jessie R. Nedrow
Joseph D. Latoche
Kathryn E. Day
Jalpa Modi
Tanushree Ganguly
Dexing Zeng
Brenda F. Kurland
Clifford E. Berkman
Carolyn J. Anderson
机构：
[1] University of Pittsburgh,Department of Radiology
[2] University of Pittsburgh,Department of Pharmacology and Chemical Biology
[3] University of Pittsburgh,Department of Bioengineering
[4] University of Pittsburgh,Department of Biostatistics
[5] Washington State University,Department of Chemistry
来源：
Molecular Imaging and Biology | 2016年 / 18卷
关键词：
PSMA; PET; Copper-64; Phosphoramidate; Irreversible inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：402 / 410
页数：8
相关论文
共 47 条
  • [41] Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [18F]DCFPyL PET Imaging
    Roy, Jyoti
    White, Margaret E.
    Basuli, Falguni
    Opina, Ana Christina L.
    Wong, Karen
    Riba, Morgan
    Ton, Anita T.
    Zhang, Xiang
    Jansson, Keith H.
    Edmondson, Elijah
    Butcher, Donna
    Lin, Frank I.
    Choyke, Peter L.
    Kelly, Kathleen
    Jagoda, Elaine M.
    MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (05) : 745 - 755
  • [42] Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [18F]DCFPyL PET Imaging
    Jyoti Roy
    Margaret E. White
    Falguni Basuli
    Ana Christina L. Opina
    Karen Wong
    Morgan Riba
    Anita T. Ton
    Xiang Zhang
    Keith H. Jansson
    Elijah Edmondson
    Donna Butcher
    Frank I. Lin
    Peter L. Choyke
    Kathleen Kelly
    Elaine M. Jagoda
    Molecular Imaging and Biology, 2021, 23 : 745 - 755
  • [43] Theranostics of Metastatic Prostate Cancer Applying 64Cu/18F/68Ga PSMA PET-CT and 177Lu Radiopharmaceuticals
    Mirzaei, Siroos
    Mohammed, Fairoz
    Zandieh, Shahin
    CURRENT RADIOPHARMACEUTICALS, 2021, 14 (04) : 354 - 358
  • [44] 64Cu-labeled panitumumab for PET imaging of EGFR plus non-small cell lung cancer: Subcutaneous and metastatic mouse models
    Wuest, Frank
    Sarrami, Nasim
    Wuest, Melinda
    Paiva, Igor
    Leier, Samantha
    Lavasanifar, Afsaneh
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S188 - S188
  • [45] First-in-human phase 1 PET study of CTT1057, a novel 18F-labeled imaging agent targeting prostate specific membrane antigen (PSMA) in prostate cancer.
    Aggarwal, Rahul Raj
    Behr, Spencer
    Seo, Youngho
    Gao, Kenneth
    Rahanfar, Vahid
    Slater, Jim
    Blecha, Joseph
    Langton-Webster, Beatrice
    Berkman, Clifford
    Vanbrocklin, Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Gallium-68 [68Ga] labeled prostate specific membrane antigen (PSMA)-11 PET/CT in primary nodal and distant staging of prostate cancer (PC) patients compared to conventional imaging modalities ( CT, MRI, bone scintigraphy): a retrospective single center study
    Dyankova, M.
    Dancheva, Z.
    Stoeva, T.
    Yordanova, T.
    Chausheva, S.
    Chaushev, B.
    Klisarova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S459 - S459
  • [47] Evaluation of a 64Cu-labeled 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODAGA)-galactose-bombesin analogue as a PET imaging probe in a gastrin-releasing peptide receptor-expressing prostate cancer xenograft model
    Kim, Min Hwan
    Park, Ji Ae
    Woo, Sang-Keun
    Lee, Kyo Chul
    An, Gwang Il
    Kim, Byoung Soo
    Kim, Kwang Il
    Lee, Tae Sup
    Kim, Chan Wha
    Kim, Kyeong Min
    Kang, Joo Hyun
    Lee, Yong Jin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 1159 - 1168
12345